Home Search
corona - search results
If you're not happy with the results, please do another search
Let’s be ‘Corona Clever’ and Catch one Before the POP. Athersys (ATHX) $1.85
It's a bit of a stretch...
Okay, it's a bit of a stretch,...
CoronaVirus Story of the Day. “How Lucky Can One Guy Be.”
LIVE QUOTE
How lucky, or how clever!
Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.
Companies With 'CoronaVirus' in Their Press Release Today:
Waitr (WTRH) up 86% - Online Food Ordering for Quarantined...
Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.
Former Eastman Kodak Scientist and Engineers Develop Liquid Germ Killer Hy-IQ® to Revolutionize the way Deadly Bacteria and Virus are Eradicated
Telehealth DTC Startup Ro is now Offering Coronavirus Assessments (ModernRetail).
Ro — a DTC telehealth company for everything from erectile dysfunction to helping quit smoking — has a new service aimed at...
Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on 180 Million Shares!
We've played many sector manias in the past (operative word 'play') such as solar, stem cells, restaurants, blockchain, marijuana, and patent monetization...
Coronavirus Stocks Still on a Tear.
The top ten losers today are down an average of 15% today (with the Dow down 7%), but the top 10 performers...
VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).
Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop...
Could Dyadic (DYAI) $5.75 Provide a Solution to Help Mass Produce Vaccines to Battle...
Dyadic (DYAI) has developed a biomanufacturing technology platform, nicknamed C1 which helps to speed the development, lower the manufacturing cost and potentially...
CoronaVirus Watch List Stocks in the News (Bloomberg, Benzinga).
INITIAL WATCHLIST: CoronaVirus Watch List | Superbug Stock Review
Aethlon Medical, Inc. (NASDAQ: AEMD) $2.40 Alpha Pro Tech, Ltd. (NYSE: APT)...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
